Key result
Endocardial PFA fails to abolish GP function in ~76% of segments unlike subsequent RF ablation.
Why the study?
Thermal PVI may act partly via collateral injury to left atrial ganglionated plexi, but the effect of cardio-selective endocardial pulsed field ablation on human ganglionated plexi function is uncertain.
Does endocardial pulsed field ablation abolish left atrial ganglionated plexi function in patients with persistent atrial fibrillation?
Cohort (n=10)
Does endocardial pulsed field ablation abolish left atrial ganglionated plexi function in patients with persistent atrial fibrillation?
Endocardial PFA does not consistently abolish LA ganglionated plexi function, supporting its cardio-selective nature and providing a mechanistic rationale for adjunctive GP ablation.
PFA may leave residual LA GP function; hypothesis-generating for adjunctive ablation in persistent AF.
BACKGROUND: Pulmonary vein isolation (PVI) using thermal energy may exert part of its antiarrhythmic effect via collateral injury to left atrial (LA) ganglionated plexi (GP). Endocardial pulsed field ablation (PFA) is designed to be cardio-selective, but its effect on human GP function is uncertain. OBJECTIVE: To systematically evaluate the effect of endocardial PFA on LA GP activity. METHODS: In this prospective cohort study, consecutive patients with persistent AF undergoing first-time PFA were enrolled. Focal high-frequency stimulation (HFS) during AF identified LA GP sites demonstrating atrioventricular delay (AVD-GPs), defined as ≥50% RR prolongation or asystole during HFS. Wide antral PFA was delivered using a pentaspline catheter to achieve PVI with posterior wall ablation. Segments with AVD-GP sites overlying PFA lesions were retested, and active AVD-GP sites were subsequently targeted with radiofrequency (RF) ablation and re-assessed. RESULTS: Ten patients (age 61.9±7.1 years, 3 (30%) female) were enrolled. At baseline, 118/591 (20.0%) sites tested met AVD-GP criteria (11.8±7.8 per patient), including 23 (19.5%) at PV ostia. Transient AVD occurred during PFA application in 4/10 (40%) patients. Post-PFA, 16/21 segments (2.0±1.1 segments/patient) with AVD-GP sites overlying PFA-treated regions demonstrated persistent AVD response. After targeted RF ablation, no previously active AVD-GP sites showed AVD response. CONCLUSION: Endocardial PFA does not consistently abolish LA GP function despite lesion delivery at overlapping sites. RF ablation reliably eliminates GP-mediated AVD. These findings support the cardio-selective nature of PFA and provide a mechanistic rationale for the prospective evaluation of adjunctive GP ablation following PFA-based PVI strategies.
No takes yet. Share an insight, caveat, or question.
Ahluwalia et al. (2026) conducted a cohort in Persistent atrial fibrillation (n=10). Endocardial pulsed field ablation vs. Radiofrequency ablation was evaluated on Persistent atrioventricular delay (AVD) response in ganglionated plexi segments. Endocardial pulsed field ablation failed to abolish ganglionated plexi function in 16 of 21 (76.2%) overlapping segments, whereas subsequent radiofrequency ablation eliminated all residual activity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: